Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]    
Net revenue $ 4,499,000 $ 1,919,000
Cost of sales 3,626,000 1,802,000
Gross profit 873,000 117,000
Operating expenses:    
Selling and administrative expenses 2,920,000 2,262,000
Research and development 1,507,000 1,341,000
Total operating expenses 4,427,000 3,603,000
Operating loss (3,554,000) (3,486,000)
Interest expense (430,000) (328,000)
Net loss $ (3,984,000) $ (3,814,000)
Net loss per share - basic and diluted $ (0.42) $ (0.75)
Weighted average number of common shares outstanding - basic and diluted 9,536,441 5,103,342